QA: Nuvalent Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001861560_2023_Nuvalent_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001861560, Nuvalent Inc.

  xvar xval
0 AssetsCurrent 477,991,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 4,468,000
4 LiabilitiesCurrent 19,481,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,377,000
9 ResearchAndDevelopmentExpense 63,731,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,254,000
13 remainder_ComprehensiveNetIncome -266,000
  yvar yval
0 Assets 482,459,000
1 Liabilities 19,481,000
2 Expenses 86,108,000
3 Revenues 0
4 StockholdersEquity 462,978,000
5 NetIncome -81,854,000
6 ComprehensiveNetIncome -81,987,000
7 BaseVar 296,284,000
8 EconomicCapitalRatio 2.85

Edgar->Model Mapping

Feature Distribution

Change over Time